Compositions for treating addiction
AssigneeCuremark, LLC
InventorsJoan M. Fallon, Matthew F. Heil
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for use in the treatment of the symptoms of an addiction is disclosed. The pharmaceutical composition contains, but is not limited to, digestive enzymes. The pharmaceutical composition may further contain a coating that surrounds a core of digestive enzymes in the form of coated particles. The pharmaceutical composition may also be encapsulated. The therapeutic agent may be manufactured by a variety of technologies.
Claims35
A method of reducing an elevated amount of ΔFos in a subject having an addiction, wherein ΔFos is elevated in the subject due to the addiction compared to a subject without the addiction, the method comprising:
- ¶
- (a) selecting the subject to be treated when the subject is diagnosed with a blood level of phenylalanine of from 1 mg/dL to 3 mg/dL or with a blood level of phenylalanine of from 60 to 120 micromolar, and
- (b) administering to the subject a therapeutically effective amount of a pharmaceutical composition that comprises digestive enzymes, wherein ΔFos is reduced upon administration of the pharmaceutical composition to the subject.
Dependencies are inferred from the claim text.